review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Ueli Aebi | Q14594735 |
P2093 | author name string | Harald Herrmann | |
Sergei V Strelkov | |||
Harald Bär | |||
Gunnar Sjöberg | |||
P433 | issue | 2 | |
P304 | page(s) | 137-152 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Journal of Structural Biology | Q3186947 |
P1476 | title | The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? | |
P478 | volume | 148 |
Q43184436 | A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization. |
Q24602132 | A novel custom resequencing array for dilated cardiomyopathy |
Q51918460 | A quantitative kinetic model for the in vitro assembly of intermediate filaments from tetrameric vimentin. |
Q64376893 | Aberrant Mitochondrial Fission Is Maladaptive in Desmin Mutation-Induced Cardiac Proteotoxicity |
Q92341308 | Alterations of redox dynamics and desmin post-translational modifications in skeletal muscle models of desminopathies |
Q45884628 | Angiogenic gene-modified myoblasts promote vascularization during repair of skeletal muscle defects |
Q35685364 | Arsenic exposure to killifish during embryogenesis alters muscle development |
Q37313697 | Build it up-Tear it down: protein quality control in the cardiac sarcomere |
Q84060258 | Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice |
Q36553090 | Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain |
Q53457776 | Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers. |
Q52313732 | Comparative gel-based proteomic analysis of chemically crosslinked complexes in dystrophic skeletal muscle. |
Q90353690 | Complex Correlations Between Desmin Content, Myofiber Types, and Innervation Patterns in the Human Extraocular Muscles |
Q90795283 | Condensed desmin and actin cytoskeletal communication in lipid droplets |
Q90076081 | Consistent expression pattern of myogenic regulatory factors in whole muscle and isolated human muscle satellite cells after eccentric contractions in humans |
Q79554774 | Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies |
Q38801420 | Desmin Mutation in the C-Terminal Domain Impairs Traction Force Generation in Myoblasts |
Q36677507 | Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure. |
Q35395372 | Desmin-related cardiomyopathy: an unfolding story |
Q36503373 | Desminopathies: pathology and mechanisms |
Q38206258 | Desmosomes in the heart: a review of clinical and mechanistic analyses |
Q42252285 | Disassembly of myofibrils and potential imbalanced forces on Z-discs in cultured adult cardiomyocytes. |
Q39798059 | Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties |
Q24627911 | Dual color photoactivation localization microscopy of cardiomyopathy-associated desmin mutants |
Q34457002 | Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing. |
Q83227151 | Evolutionary loss of foot muscle during development with characteristics of atrophy and no evidence of cell death |
Q41504807 | Flow birefringence property of desmin filaments |
Q40308202 | Forced expression of desmin and desmin mutants in cultured cells: impact of myopathic missense mutations in the central coiled-coil domain on network formation. |
Q42736271 | Head and rod 1 interactions in vimentin: identification of contact sites, structure, and changes with phosphorylation using site-directed spin labeling and electron paramagnetic resonance |
Q30299996 | Improved neurological outcome by intramuscular injection of human amniotic fluid derived stem cells in a muscle denervation model |
Q39837470 | Interference of amino-terminal desmin fragments with desmin filament formation |
Q37419742 | Intermediate filament diseases: desminopathy. |
Q37241400 | Intermediate filaments: primary determinants of cell architecture and plasticity |
Q59792842 | Intra-amniotic Sildenafil Treatment Modulates Vascular Smooth Muscle Cell Phenotype in the Nitrofen Model of Congenital Diaphragmatic Hernia |
Q89862507 | Is Desmin Propensity to Aggregate Part of its Protective Function? |
Q57753190 | Lasp-2 expression, localization, and ligand interactions: a new Z-disc scaffolding protein |
Q28295898 | Mechanistic basis of desmosome-targeted diseases |
Q34070196 | Metallothionein as a clonable high-density marker for cryo-electron microscopy |
Q37258743 | Molecular pathology of myofibrillar myopathies. |
Q30478290 | Monitoring intermediate filament assembly by small-angle x-ray scattering reveals the molecular architecture of assembly intermediates |
Q24313412 | Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle |
Q28533968 | N-acetyl-L-cysteine prevents stress-induced desmin aggregation in cellular models of desminopathy |
Q30832463 | Nebulette is a powerful cytolinker organizing desmin and actin in mouse hearts |
Q36884249 | Primary desminopathies |
Q33450135 | Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer |
Q35942142 | Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D. |
Q45880234 | Satellite cell number and cell cycle kinetics in response to acute myotrauma in humans: immunohistochemistry versus flow cytometry |
Q34075709 | Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages |
Q52889077 | Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors. |
Q48190393 | The MTM1-UBQLN2-HSP complex mediates degradation of misfolded intermediate filaments in skeletal muscle. |
Q33679100 | The role of muscle cells in regulating cartilage matrix production. |
Q24633116 | The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin |
Q35148384 | Tissue specific dysregulated protein subnetworks in type 2 diabetic bladder urothelium and detrusor muscle |
Q40758276 | Tissue-engineered artificial oesophagus patch using three-dimensionally printed polycaprolactone with mesenchymal stem cells: a preliminary report |
Q37241396 | Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease |
Q34776342 | Two desmin gene mutations associated with myofibrillar myopathies in Polish families |
Q40251775 | Variable pathogenic potentials of mutations located in the desmin alpha-helical domain. |
Q34395548 | Vimentin as an integral regulator of cell adhesion and endothelial sprouting |
Q36220005 | Voltage-Dependent Anion Channel 1(VDAC1) Participates the Apoptosis of the Mitochondrial Dysfunction in Desminopathy |
Q40765741 | Vps34 regulates myofibril proteostasis to prevent hypertrophic cardiomyopathy |
Q33748201 | Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis |
Q33779909 | αB-crystallin is a sensor for assembly intermediates and for the subunit topology of desmin intermediate filaments. |
Search more.